[{"Assets_0_FY_USD":773855000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.0,"CommonStockSharesConverted_0_FY_shares":121482671.0,"CommonStockSharesOutstanding_0_FY_shares":121482671.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-44653000.0,"NetIncomeLossConverted_1_FY_USD":-30509000.0,"NetIncomeLossConverted_4_FY_USD":-211505000.0,"StockholdersEquity_0_FY_USD":703164000.0,"EarningsPerShareBasic_1_FY_USD":-0.37,"EarningsPerShareBasic_4_FY_USD":-7.31,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190308"}]